Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupus Erythematosus, Systemic
|
1172 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.020 | 2 | 2014 | 2018 | |||||
Rheumatoid Arthritis
|
2387 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.020 | 2 | 2012 | 2018 | |||||
AIDS related complex
|
43 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2018 | 2018 | |||||
Autoimmune Diseases
|
428 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2017 | 2017 | |||||
Azoospermia
|
70 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2007 | 2007 | |||||
Childhood Osteosarcoma
|
151 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2018 | 2018 | |||||
Chronic gastritis
|
11 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2005 | 2005 | |||||
Gastric Cardia Carcinoma
|
13 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2004 | 2004 | |||||
Hematologic Neoplasms
|
60 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2014 | 2014 | |||||
Malignant Female Reproductive System Neoplasm
|
5 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2017 | 2017 | |||||
Osteosarcoma
|
178 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2018 | 2018 | |||||
Osteosarcoma of bone
|
151 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2018 | 2018 | |||||
premalignant lesion
|
5 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.010 | 1 | 2005 | 2005 | |||||
Head and Neck Carcinoma
|
118 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2009 | 2014 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2009 | 2014 | ||||
Malignant neoplasm of prostate
|
1082 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
Prostate carcinoma
|
1168 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.040 | 0.500 | 4 | 2007 | 2014 | ||||
cervical cancer
|
268 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Cervix carcinoma
|
283 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Malignant tumor of cervix
|
245 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2008 | 2017 | ||||
Nasopharyngeal carcinoma
|
320 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.050 | 0.600 | 5 | 2006 | 2018 | ||||
Malignant neoplasm of thyroid
|
103 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 0.667 | 6 | 2012 | 2019 | ||||
Thyroid carcinoma
|
145 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 0.667 | 6 | 2012 | 2019 | ||||
Thyroid Neoplasm
|
135 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.060 | 0.667 | 6 | 2012 | 2019 | ||||
Malignant neoplasm of skin
|
38 | 0.474 | 0.800 | 19 | 43553422 | missense variant | G/A | snv | 9.5E-02 | 7.0E-02 | 0.030 | 0.667 | 3 | 2004 | 2011 |